Ask AI
ProCE Banner Events

Share

CLL Challenge! Interrogating the Latest Evidence on Patient Priorities and Novel Targeted Therapies

Most surveyed patients with chronic lymphocytic leukemia (CLL) say they were offered only one treatment option, which raises important questions about counseling and shared decision-making in CLL. In this live symposium, learners will examine evidence on CLL, including established and emerging targeted therapeutics for CLL, and learn how to uncover and integrate patient values, preferences, and lifestyle considerations for treatment selection and sequencing. 

Friday Satellite Symposium preceding the 68th ASH Annual Meeting and Exposition. 

Physicians ABIM MOC: maximum of 2.00 Medical Knowledge MOC points

Physicians: maximum of 2.00 AMA PRA Category 1 Credits™

Physician Assistants/Physician Associates: 2.00 AAPA Category 1 CME credits

Pharmacists: 2.00 contact hours (0.2 CEUs)

Nurse Practitioners/Nurses: 2.00 Nursing contact hours

Who Should Attend

This educational activity is intended for hematologists, oncologists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals who care for individuals with CLL/SLL.

Time and location

Friday, December 11, 2026

11:00 AM - 1:30 PM Central Time (CT)

In-person

11:30 AM - 1:30 PM Central Time (CT)

Virtual

Ernest N. Morial Convention Center
900 Convention Center Blvd
New Orleans, Louisiana 70130

Room: 208-210

Agenda

CLL Society’s Chief Medical Officer Presents Patients’ Insights From Surveys

CLL Standard of Care in 2026 and Practice-Changing Trials

Second Line and Beyond: Patient-Based Treatment Sequencing

Location

Venue Name

Ernest N. Morial Convention Center

Address

Ernest N. Morial Convention Center
900 Convention Center Blvd
New Orleans, Louisiana 70130

Room Name

Room: 208-210

CME/CE Info

Goal Statement
This activity aims to improve learners’ knowledge, confidence, and competence in providing patient-centered management of individuals with CLL/SLL.

Target Audience
This educational activity is intended for hematologists, oncologists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals who care for individuals with CLL/SLL.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Support patient engagement in the management of CLL/SLL through effective shared decision-making and communication strategies
  • Compare the mechanisms of action and clinical rationales for novel targeted therapies that are approved vs under investigation for management of CLL/SLL
  • Recommend individualized treatment sequences leveraging novel targeted and/or cellular therapies for eligible patients with CLL/SLL in alignment with patient preferences, clinical evidence, and expert recommendations
  • Assess the clinical implications of emerging efficacy and safety data for novel targeted and cellular therapies on treatment sequencing in CLL/SLL
  • Apply best practices for biomarker testing before treatment initiation and at disease progression to guide optimal therapy selection and sequencing in patients with CLL/SLL

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC dba Decera Clinical Education and CLL Society. Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 2.0 contact hours.

Continuing Pharmacy Education

Clinical Care Options, LLC dba Decera Clinical Education designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-9999-26-390-L01-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification

Title: A blue and black sign with white textDescription automatically generated

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 2.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through Decera Clinical Education’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Decera Clinical Education permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

IPCE Credit Designation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/657115052be04.jpg

This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with CLL Society

Clinical Care Options, LLC dba Decera Clinical Education

Supporter

Supported by educational grants from AstraZeneca, BeOne Medicines, and Lilly.

AstraZeneca

Lilly

BeOne Medicines

Partner

CLL Society

CLL Society

Contact Information

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191

 

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.